Immix Biopharma


Immix Biopharma, Inc. (ImmixBio™) is a clinical-stage biopharmaceutical company pioneering a novel class of Tissue-Specific Therapeutics (TSTx)™ in oncology and inflammation.

Industries

Employees

1-10

Links


Org chart

Ilya Rachman
Co-Founder & CEO
Collapse
Gabriel Morris
CFO & Director
Graham Ross
Chief Medical Officer & Head of Clinical Development
Eva Altow
Head Of Executive Office
Hunter Stavroff
Senior Associate, Corporate Strategy

Board & advisors

Sean Senn
Co-Founder
Jane Buchan
Director
Jason Hsu
Director
Carey Ng
Director
Larry Norton
Chair, Scientific Advsiory Board
Sant Chawla
Scientific Advisor
Razelle Kurzrock
Scientific Advisor
Galit Lahav
Scientific Advisor
Gary Schiller
Scientific Advisor
George W. Sledge
Scientific Advisor


Offices